Health facilities served as the entry point for enrolment into the study population. A three-stage sampling strategy was deployed; At the first stage, only health centre level three and above in the study districts were purposively selected. In the second stage, eight villages with similarly high numbers of malaria cases were selected in each health facility catchment area in each district. This was based on malaria data for the same period of the preceding year extracted from health facilities’ outpatient registers. This data was then used to calculate malaria attack rates among children aged 3–59 months based on numbers of confirmed cases presenting at health centres divided by their catchment area populations. In the control district, communities bordering the intervention districts were not selected to avoid ‘leakage’ across district boundaries. In the third stage, all households in each of the eight selected villages were enumerated and twenty-five households with at least one SMC-eligible child were selected in each village using systematic sampling. One SMC-eligible child was then randomly selected from each household. This resulted in a sample of 200 children per district or 600 across the three study districts. To ensure adherence to the full three-day SPAQ regimen, children enrolled into the study in the intervention districts received all doses as directly observed therapy under the supervision of a VHT distributor. In the event of death of child under study, WHO’s verbal autopsy tool was applied to determine the cause of death [25 ]. SMC eligibility was defined according to the standard SMC protocol.
Free full text: Click here